Experience. Commitment. Results.
Elevation Oncology, Inc. (NASDAQ: ELEV) related to its sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% … Read more
Crown Electrokinetics Corp. (OTCMKTS: CRKN) related to its sale to Crown EK Acquisition LLC for $3.15 per share.
Blueprint Medicines Corporation (NASDAQ: BPMC) related to it sale to Sanofi. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR … Read more
Atai Life Sciences N.V. (NASDAQ: ATAI) related to the acquisition of Beckley Psytech Limited.
Heliogen, Inc. (OTCQX: HLGN) related to its sale to Zeo Energy Corp.. Upon closing of the proposed transaction, Heliogen’s securityholders will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment … Read more
Know Labs, Inc. (NYSE: KNW) related to its sale to Goldeneye 1995 LLC. Under the terms of the agreement, the Buyer will acquire that number of shares of the Company’s common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred equity and provide … Read more
Provident Bancorp, Inc. (NASDAQ: PVBC) related to its sale to NB Bancorp, Inc. Under the terms of the proposed transaction, Provident shareholders will receive for each share of Provident common stock, at the holder’s election, either (i) 0.691 shares of NB Bancorp common stock or (ii) $13.00 in cash.
Signing Day Sports, Inc. (NYSE: SGN) related to its merger with One Blockchain LLC. Upon completion of the proposed transaction, Signing Day shareholders are expected to own approximately 8.5% of the combined company.
Sitio Royalties Corp. (NYSE: STR) related to its sale to Viper Energy, Inc. The merger consideration will consist of 0.4855 shares of Class A common stock of a new holding company (“New Viper”) for each share of Sitio Class A common stock, 0.4855 units of Viper’s operating subsidiary, Viper Energy Partners LLC, for each unit … Read more
Streamline Health Solutions, Inc. (NASDAQ: STRM) relating to its sale to MDaudit for $5.34 per share.